A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Fixed-Flexible Dose, Parallel-Group Study of Lurasidone for the Treatment of Bipolar I Depression
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression
Inclusion Criteria:
Exclusion Criteria:
Garden Grove, California 92645, United States
Pico Rivera, California 90660, United States
San Diego, California 92102, United States
Bradenton, Florida 34208, United States
Maitland, Florida 32751, United States
West Palm Beach, Florida 33407, United States
Lake Charles, Louisiana 70601, United States
Albuquerque, New Mexico 87109, United States
Raleigh, North Carolina 27609, United States
Kolejni 429-5, Prague, Czechia
Brno - Mesto, 602 00, Czechia
Vijaywada, Andh Prad 520002, India
Bucdresti, 010825, Romania
Vinnitsia, 21018, Ukraine